Matthieu Duchmann - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Matthieu Duchmann

Showing results (21-30 of 26) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 26 results.

Leukemia|April 27, 2022

Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemiaBryann Pardieu, Justine Pasanisi, Frank Ling, et al.

Nature Cancer|May 30, 2024

Targeting a lineage-specific PI3Kɣ-Akt signaling module in acute myeloid leukemia using a heterobifunctional degrader moleculeLois M Kelly, Justine C Rutter, Kevin H Lin, et al.

Blood Advances|September 9, 2025

Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignanciesMichael Loschi, Marie-Charlotte Villy, Jacques-Emmanuel Galimard, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2022

Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life ExperienceVincent Marmouset, Justine Decroocq, Sylvain Garciaz, et al.

Science Translational Medicine|July 8, 2026

Splicing-associated network PAK1-CLK1/4-SRRM1 is a vulnerability to overcome chemoresistance in human and mouse acute myeloid leukemiaCamille Vaganay, Frank Ling, Lois M Kelly, et al.

Cell Stem Cell|February 3, 2023

Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemiaMarie Sebert, Stéphanie Gachet, Thierry Leblanc, et al.

Pageof 3

Search research articles

Showing results (21-30 of 26) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 26 results.

Leukemia|April 27, 2022

Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemiaBryann Pardieu, Justine Pasanisi, Frank Ling, et al.

Nature Cancer|May 30, 2024

Targeting a lineage-specific PI3Kɣ-Akt signaling module in acute myeloid leukemia using a heterobifunctional degrader moleculeLois M Kelly, Justine C Rutter, Kevin H Lin, et al.

Blood Advances|September 9, 2025

Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignanciesMichael Loschi, Marie-Charlotte Villy, Jacques-Emmanuel Galimard, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2022

Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life ExperienceVincent Marmouset, Justine Decroocq, Sylvain Garciaz, et al.

Science Translational Medicine|July 8, 2026

Splicing-associated network PAK1-CLK1/4-SRRM1 is a vulnerability to overcome chemoresistance in human and mouse acute myeloid leukemiaCamille Vaganay, Frank Ling, Lois M Kelly, et al.

Cell Stem Cell|February 3, 2023

Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemiaMarie Sebert, Stéphanie Gachet, Thierry Leblanc, et al.

Pageof 3